Retatrutide is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Lyophilized (freeze-dried) Retatrutide should be stored at -20°C for long-term stability. Once reconstituted with bacteriostatic water, store at 2-8°C (refrigerated) and use within 4-6 weeks. Never freeze reconstituted peptides.
How Do You Store Retatrutide?
Proper storage is critical for maintaining Retatrutide's potency and safety. As a Triple hormone receptor agonist, Retatrutide is sensitive to heat, light, and moisture — improper storage can render it ineffective or harmful.
How Do You Store Lyophilized Retatrutide?
Unreconstituted (freeze-dried) Retatrutide: Store at -20°C (standard freezer) for maximum shelf life of 12-24+ months. Keep the vial sealed and away from moisture.
Room temperature storage is acceptable for short periods (shipping) but degrades potency over weeks. Refrigerator (2-8°C) storage extends this to several months.
How Do You Store Reconstituted Retatrutide?
After mixing with bacteriostatic water: Store at 2-8°C (standard refrigerator). Use within 4-6 weeks for optimal potency.
Never freeze reconstituted Retatrutide. Freezing and thawing damages the peptide structure. The bacteriostatic water's benzyl alcohol preservative is what allows the 4-6 week window — sterile water would give you only days.
Keep the vial upright and away from the refrigerator door (temperature fluctuations from opening/closing).
How Do You Know if Retatrutide Has Gone Bad?
Reconstituted Retatrutide should be clear and colorless. If you see cloudiness, particles, or discoloration — discard it. These indicate bacterial contamination or peptide degradation.
If stored properly, degradation is gradual and may not be visually apparent. This is why the 4-6 week window for reconstituted peptides exists.
Can You Travel With Retatrutide?
Lyophilized Retatrutide can be shipped with cold packs and insulation. For short trips, a small cooler bag with an ice pack maintains adequate temperature.
Reconstituted Retatrutide is more temperature-sensitive and should be kept refrigerated during travel if possible.
Bottom Line on Retatrutide Storage
Freeze-dried: -20°C, sealed, 12+ months. Reconstituted: 2-8°C, use within 4-6 weeks, never freeze. Source from vendors who ship with proper cold-chain packaging.
Complete Guide
Retatrutide : Benefits, Dosage, Side Effects & Research
Related Reading
- Retatrutide Dosage Guide
- Retatrutide Benefits
- Retatrutide Side Effects
- Retatrutide Stacking Guide
- Retatrutide Cycle Guide
- Retatrutide Research
Calculate Your Retatrutide Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Retatrutide.
Open Calculator →Research-Grade Sourcing
If you're going to research Retatrutide, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Retatrutide?
Retatrutide (Retatrutide (LY3437943)) is a Triple hormone receptor agonist. Novel synthetic peptide developed by Eli Lilly targeting GIP, GLP-1, AND glucagon receptors simultaneously. It is researched for substantial weight loss (up to 24.2%), improved glycemic control, improved liver steatosis, reduced diabetic kidney disease markers.
What is the recommended Retatrutide dosage?
Common dosages: 4-12 mg weekly (maintenance after titration) administered once weekly via subcutaneous injection. Cycle length: 48+ weeks (continuous therapy in trials). Half-life: approximately 4-5 days. Use our peptide calculator for exact reconstitution math.
What are the side effects of Retatrutide?
Gastrointestinal effects predominate: diarrhea, vomiting, constipation, nausea. Generally manageable and dose-dependent. Potential pancreatitis risk similar to GLP-1 agonists.
Is Retatrutide safe?
Retatrutide has shown a preliminary safety profile in research. Not FDA-approved as of March 2026. NDA filing expected late 2026-early 2027. All research should follow appropriate safety protocols.